| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/29/2008 | US20080125498 Treatment of neurodegenerative diseases and conditions using par1 antagonists |
| 05/29/2008 | US20080125493 Use of agomelatine in obtaining medicaments intended for the treatment of periventricular leukomalacia |
| 05/29/2008 | US20080125491 screening for neuroprotectants such as -Isobutyryl-1,4-a-dimethyl-1,2,3,4,4a,9,10,10a-octahydro-phenanthrene-1-carboxylic acid amide, used for the prevention of neurodegenerative diseases and cardiovascular disorders |
| 05/29/2008 | US20080125483 3-Aminomethyl-5-methyl-hexanoic acid 1-ethyloxycarbonyloxy-ethyl ester; epilepsy, depression, anxiety, psychosis, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, panic, pain |
| 05/29/2008 | US20080125481 Isoflavone metabolites |
| 05/29/2008 | US20080125477 7-(acryloyl) indole compositions and methods of making and using same |
| 05/29/2008 | US20080125467 (4-methylthiazol-2-yl)methyl 9-hydroxy-8-isobutyl-14-isopropyl-11,18-dimethyl-2,6,12,15-tetraoxo-3,7,13,16-tetraazanonadecan-5-ylcarbamate; Alzheimer's disease |
| 05/29/2008 | US20080125466 Useful in the treatment of conditions associated with pathological receptor activation; inhibiting binding of vanilloid ligand to a capsaicin receptor; (4-tert-Butyl-phenyl)-[1,1-dioxo-6-(3-trifluoromethyl-pyridin-2-yl)-1H-1?6-benzo[d]isothiazol-3-yl]-amine |
| 05/29/2008 | US20080125460 inducible nitric oxide synthase inhibitors; acute or chronic inflammatory diseases of of peripheral organs and the central nervous system; 6-pyridinyl imidazo-[4,5-b]pyridine compounds; 2-[2-(4-Methoxypyridin-2-yl)ethyl]-6-(pyridin-4-yl)-3H-imidazo-[4,5-b]pyridine |
| 05/29/2008 | US20080125455 disorders of the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus; sleep apnea; (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine and (S)-1-[1-(1,2,3,6,7,8-hexahydrocyclopent[g]indolyl)]-2-propylamine |
| 05/29/2008 | US20080125431 E.g., 3-(2'-Morpholin-4-ylmethyl-biphenyl-4-ylmethyl)-1-oxa-3-aza-spiro[4.5]decan-2-one; acute and chronic neurological and psychiatric disorders and chronic and acute pain disorders; Alzheimer's disease; schizophrenia; antidepressants; bipolar disorders; antiischemic agents; cardiotonic agents |
| 05/29/2008 | US20080125427 Novel Inhibitors of Rho-Kinases |
| 05/29/2008 | US20080125426 7-(4-Chlorophenyl)-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; reversible inhibitors of cysteine proteases S, K, F, L, B; diseases associated with Cathepsin S; antiinflammatory agent, autoimmune diseases; asthma, rheumatoid arthritis, multiple sclerosis, Alzheimer's and Crohn's disease |
| 05/29/2008 | US20080125419 Benzothiazole derivatives with activity as adenosine receptor ligands |
| 05/29/2008 | US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors |
| 05/29/2008 | US20080125416 Sigma Receptor Inhibitors |
| 05/29/2008 | US20080125392 Glycolipids |
| 05/29/2008 | US20080125373 Motoneuronotrophic factors (MNTF); nerve growth factors; spinal cord injuries; neurodegenerative diseases |
| 05/29/2008 | US20080124743 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (u1) |
| 05/29/2008 | US20080124413 Novel composition containing extracts of butyrospermum parkii and the use of such a composition for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation hypersensitivity or pain |
| 05/29/2008 | US20080124410 Use Of Lavender Oil For The Prophylaxis And Treatment Of Neurasthenia, Somatization Disorders And Other Stress-Associated Diseases |
| 05/29/2008 | US20080124403 e.g., histone deacetylase inhibitor; includes electrolyte supplementation; to prevent unwanted side effects such as cardiac side effects |
| 05/29/2008 | US20080124395 Formulations and devices for treatment or prevention of neural ischemic damage |
| 05/29/2008 | US20080124390 Antidepressants for treating manic disorders, psychosis; comprising ethyl cellulose, talc, polyvinylpyrrolidone; time-release dosage form; once daily |
| 05/29/2008 | US20080124346 Chimeric metal binding protein for use in prevention and treatment of cancer, diabetes, cardiovascular disease, obesity, metabolic disease, neurodegenerative disease, gastrointestinal disease, autoimmune disease, rheumatological disease and infectious disease. |
| 05/29/2008 | US20080124322 Activation and inhibition of the immune system |
| 05/29/2008 | US20080124315 Method of reducing CRF receptor mRNA |
| 05/29/2008 | US20080124283 Method of Providing Fast Relief to a User of a Nicotine Chewing Gum |
| 05/29/2008 | US20080124280 Thyroid Hormone Analogs and Methods of Use |
| 05/29/2008 | DE112005001269T5 Polysaccharidextrakt aus Lycium barbarum als neuroprotektives Mittel gegen ß-Amyloidpeptidneurotoxizität Lycium barbarum from Polysaccharidextrakt as a neuroprotective agent against beta-amyloid peptide toxicity EUR |
| 05/29/2008 | DE102006056458A1 Arzneimittelzubereitung von Tramadol und Acetaminophen The pharmaceutical preparation of tramadol and acetaminophen |
| 05/29/2008 | CA2683114A1 Cells expressing alpha-synuclein and uses therefor |
| 05/29/2008 | CA2670439A1 Anticonvulsive pharmaceutical compositions |
| 05/29/2008 | CA2670418A1 N-(methyl)-1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimers's |
| 05/29/2008 | CA2670405A1 Combination treatments for alzheimer's disease and related neurodegenerative diseases |
| 05/29/2008 | CA2670404A1 Heteromonocyclic compound and use thereof |
| 05/29/2008 | CA2670372A1 Depsipeptides and their therapeutic use |
| 05/29/2008 | CA2670223A1 Depsipeptides and their therapeutic use |
| 05/29/2008 | CA2669975A1 Ph.alpha.1b toxin, cdna of ph.alpha.1b toxin gene, pharmaceutical compositions containing ph.alpha.1b toxin, processes for their obtention and product |
| 05/29/2008 | CA2669839A1 2-hydroxy-1,3-diaminopropane derivatives |
| 05/29/2008 | CA2669124A1 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity |
| 05/29/2008 | CA2669084A1 Pak modulators |
| 05/29/2008 | CA2668205A1 2-alkyl-indazole compounds for the treatment of certain cns-related disorders |
| 05/29/2008 | CA2665726A1 Pharmaceutical compositions |
| 05/29/2008 | CA2664126A1 The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders |
| 05/29/2008 | CA2650227A1 Substituted pyrazolopyrimidines |
| 05/28/2008 | EP1925614A1 Anxiolytic agents with reduced sedative and ataxic effects |
| 05/28/2008 | EP1925315A2 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 05/28/2008 | EP1925314A1 Pharmaceutical composition with synergistic anticonvulsant effect |
| 05/28/2008 | EP1925308A1 Low hygroscopic aripiprazole (crystal G) drug substance and processes for the preparation thereof |
| 05/28/2008 | EP1925305A1 Ih channel inhibitors for the promotion of wakefulness |
| 05/28/2008 | EP1925304A1 Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents |
| 05/28/2008 | EP1925302A1 Dietary or pharmaceutical compositions containing tricyclic diterpenes and derivatives thereof for the treatment of depression |
| 05/28/2008 | EP1925213A1 Dietary and pharmaceutical compositions comprising a sage extract comprising a mixture of tricyclic diterpenes and their derivatives and their uses |
| 05/28/2008 | EP1924578A2 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| 05/28/2008 | EP1924560A1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 05/28/2008 | EP1924287A2 Method of treating depression using a tnf-alpha antibody |
| 05/28/2008 | EP1924274A1 Modulation of cell fates and activities by phthalazinediones |
| 05/28/2008 | EP1924261A1 Stable solid formulation of sertindole |
| 05/28/2008 | EP1924251A1 Topical formulations containing o-desmethyl venlafaxine (odv) or its salts |
| 05/28/2008 | EP1781644B1 Macrocyclic beta-secretase inhibitors |
| 05/28/2008 | EP1711177B1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS |
| 05/28/2008 | EP1673078B1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/28/2008 | EP1660475B1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/28/2008 | EP1633355B1 Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor |
| 05/28/2008 | EP1577294A4 S-substituted n-1- (hetero)aryl alkyl-n - (hetero)aryl alkylysothiocarbamides, method for the production thereof, physiologically active s-substituted n-1- (hetero )aryl alkyl-n - (hetero)aryl alkylysothiocarbamides,a pharmaceutical compound and curing method |
| 05/28/2008 | EP1554282B1 Morphinan derivatives substituted in position 14 and quaternary ammonium salts thereof, method for production and use thereof |
| 05/28/2008 | EP1537115B1 Selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 05/28/2008 | EP1496898B1 Tyrosine kinase inhibitors |
| 05/28/2008 | EP1494992B1 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 05/28/2008 | EP1467769B1 Use of a resinate in the preparation of a formulation for smoking cessation |
| 05/28/2008 | EP1450773B1 Transdermal therapeutic system provided with improved long-term carrying comfort |
| 05/28/2008 | EP1425031B1 Hdl for the treatment of stroke and other ischemic conditions |
| 05/28/2008 | EP1420020B1 4-oxoimidazolidine-2-spiropiperidine derivative |
| 05/28/2008 | EP1404864A4 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways |
| 05/28/2008 | EP1399744B1 Epf receptor assays, compounds and therapeutic compositions |
| 05/28/2008 | EP1399155B1 Small molecules useful in the treatment of inflammatory disease |
| 05/28/2008 | EP1381356B1 Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
| 05/28/2008 | EP1368063B1 Complex of modafinil and cyclodextrin |
| 05/28/2008 | EP1301604B1 Substrates and assays for beta-secretase activity |
| 05/28/2008 | CN101189262A Humanin receptor or humanin-like polypeptide receptor |
| 05/28/2008 | CN101189233A Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acety lcholine receptors |
| 05/28/2008 | CN101189232A 3-aryloxy-8-aza-bicyclo [3.2.1.] oct-6-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/28/2008 | CN101189228A Bicyclic [3.1.0] heteroaryl amides as type I glycine transport inhibitors |
| 05/28/2008 | CN101189221A AMPA receptor potentiators |
| 05/28/2008 | CN101189219A Preventive or remedy for depression or anxiety neurosis |
| 05/28/2008 | CN101189215A Benzoxazocines and their therapeutic use |
| 05/28/2008 | CN101189211A Quinoline derivatives as NK3 anatgonists |
| 05/28/2008 | CN101189004A Treatment of pain |
| 05/28/2008 | CN101189002A Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
| 05/28/2008 | CN101186921A Novel gene Xsynuclein for xenopus laevis GRK family |
| 05/28/2008 | CN101186596A Novel compound tatarine D and separating identification method thereof |
| 05/28/2008 | CN101186590A Crystalline and pure modafinil, and process of preparing the same |
| 05/28/2008 | CN101186580A Gaba analogs and its medical compositions |
| 05/28/2008 | CN101185742A Chinese traditional medicinal composition for treating epilepsy |
| 05/28/2008 | CN101185727A Traditional Chinese medicine preparation containing ginseng and pilose antler capable of nourishing heart and nourishing kidney |
| 05/28/2008 | CN101185709A Chinese herbal medicine for treating apoplexy sequelae (hemiparalysis) |
| 05/28/2008 | CN101185701A Chemical medicine and natural medicine composition for treating diabetes chronic complication and preparation method thereof |
| 05/28/2008 | CN101185662A Method and use for preparing novel medicine for treating diabetes prepared from tuber fern |